GDPbio: Genome based prediction of Diseases and Personal medicines using Bioinformatics

G.P.S. Raghava | Department of Computational Biology | IMTECH | CRDD | Team Members | Contact | FAQ
Concept of GDPbio
 About GDPbio
 Diseases prediction
 Personal Drugs
 Vaccines
 Biomarkers

Diseases and Genes
 Cancer
 Useful Databases
 Diseases Susceptiblity
 Diseases Diagnosis
 Diseases Management
 Diseases Screening

Personal Genomes
 Sequencing Projects
 Genomic Databases
 
 Problems faced

Personalized Medicines
 Wiki Pages
 Important Links
 Slides (PPT/PDF)
   Challenges

<< Previous

Cancer continue..

Cancer Screening
It is an attempt to detect unsuspected cancers in an asymptomatic population. Screening tests suitable for large numbers of healthy people must be relatively affordable, safe, noninvasive procedures with acceptably low rates of false positive results. If signs of cancer are detected, more definitive and invasive follow up tests are performed to confirm the diagnosis. Screening for cancer can lead to earlier diagnosis in specific cases. Early diagnosis may lead to extended life, but may also falsely prolong the lead time to death through lead time bias or length time bias. A number of different screening tests have been developed for different malignancies, some of tests are:
  • Breast cancer screening (by breast self-examination).
  • Colorectal cancer can be detected through fecal occult blood testing and colonoscopy.
  • Testicular self-examination is recommended for men beginning at the age of 15 years to detect testicular cancer.
  • Cervical cancer screening via the Pap smear.